Amcad Awarded the Industrial Innovation Award from Taiwan President Tsai
19-08-12
AmCad BioMed is pleased to announce our accomplishment in becoming the first medical imaging AI developing company listed in the Taiwan OTC market. AmCad owns 6 proprietary Medical Imaging AI products, of which 4 have received FDA 510(K) clearance in the U.S. Among the innovative company’s listed products are the OSA detecting AmCAD UO, which recently was awarded the prestigious Industrial Innovation Award from Taiwan President Tsai Ing-Wen.
are the trademarks owned by AmCad in Taiwan and/or in other countries. Unauthorized use of the AmCAD trademarks is prohibited unless specifically authorized.